Video

MaxCyte Cell & Gene Tech Expo August 2026: Cell Therapy

Scaling non-viral CAR-T development from discovery to GMP manufacturing remains one of the more demanding transitions in advanced therapy research. In this Cell & Gene Tech Expo presentation, MaxCyte's Isabel Daher introduces a high-throughput electroporation platform designed to address that challenge. The system supports simultaneous optimization of up to 96 samples, reducing the time and resources required to identify optimal conditions for gene editing and non-viral delivery.

Critically, the same platform scales to GMP manufacturing, eliminating the process discontinuities that typically complicate tech transfer. Researchers seeking a reproducible, scalable approach to non-viral CAR-T development should watch this session in full.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

MaxCyte, Inc.